From: Communicating statin evidence to support shared decision-making
5Â % 10-year risk | 7.5Â % 10-year risk | 10Â % 10-year risk | 15Â % 10-year risk | 20Â % 10-year risk | 30Â % 10-year risk | ||||||
with statin | without statin | with statin | without statin | with statin | without statin | with statin | without statin | with statin | without statin | with statin | without statin |
3.75Â % | 5Â % | 5.63Â % | 7.5Â % | 7.5Â % | 10Â % | 11.25Â % | 15Â % | 15Â % | 20Â % | 22.5Â % | 30Â % |
ARR = 1.25 % | ARR = 1.88 % | ARR = 2.5 % | ARR = 3.75 % | ARR = 5 % | ARR = 7.5 % | ||||||
NNT = 80 | NNT = 53 | NNT = 40 | NNT = 27 | NNT = 20 | NNT = 13 | ||||||
2.5Â % 5-year risk | 3.75Â % 5-year risk | 5Â % 5-year risk | 7.5Â % 5-year risk | 10Â % 5-year risk | 15Â % 5-year risk | ||||||
with statin | without statin | with statin | without statin | with statin | without statin | with statin | without statin | with statin | without statin | with statin | without statin |
1.88Â % | 2.5Â % | 2.81Â % | 3.75Â % | 3.75Â % | 5Â % | 5.63Â % | 7.5Â % | 7.5Â % | 10Â % | 11.25Â % | 15Â % |
ARR = 0.63 % | ARR = 0.94 % | ARR = 1.25 % | ARR = 1.88 % | ARR = 2.5 % | ARR =3.75 % | ||||||
NNT = 160 | NNT = 107 | NNT = 80 | NNT = 53 | NNT = 40 | NNT = 27 |